EPS (Diluted) for Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's current diluted EPS (TTM) is $5.44. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ILMN
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$5.44
YoY change
-170.7%
5Y CAGR
+4.2%
Peak year (2019)
$6.72
Latest annual
$5.44
EPS (Diluted) history chart for Illumina (ILMN) from 1999 to 2025
EPS (Diluted) history table for Illumina (ILMN) from 1999 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $5.44 | -170.7% | ||
| 2024 | $-7.69 | +4.6% | ||
| 2023 | $-7.35 | -73.8% | ||
| 2022 | $-28.05 | -655.4% | ||
| 2021 | $5.05 | +14.0% | ||
| 2020 | $4.43 | -34.1% | ||
| 2019 | $6.72 | +21.3% | ||
| 2018 | $5.54 | +12.8% | ||
| 2017 | $4.91 | +56.9% | ||
| 2016 | $3.13 | +1.0% | ||
| 2015 | $3.10 | +30.8% | ||
| 2014 | $2.37 | +163.3% | ||
| 2013 | $0.90 | -20.4% | ||
| 2012 | $1.13 | +82.3% | ||
| 2011 | $0.62 | -28.7% | ||
| 2010 | $0.87 | +64.2% | ||
| 2009 | $0.53 | +39.5% | ||
| 2008 | $0.38 | -114.8% | ||
| 2007 | $-2.57 | -726.8% | ||
| 2006 | $0.41 | -257.7% | ||
| 2005 | $-0.26 | +199.5% | ||
| 2004 | $-0.09 | -79.3% | ||
| 2003 | $-0.42 | -35.4% | ||
| 2002 | $-0.65 | +54.8% | ||
| 2001 | $-0.42 | +27.3% | ||
| 2000 | $-0.33 | -83.2% | ||
| 1999 | $-1.96 | — |
EPS (Diluted) values are taken from Illumina's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for Illumina (ILMN) came in at $5.44 – plunged 170.7% year-over-year.
Through 2020–2025 (5 years), Illumina diluted EPS delivered a +4.2% annualised rate; with the latest reading among the more recent periods of the dataset.
Illumina diluted EPS peaked at $6.72 in 2019; the latest annual figure is $5.44 in 2025 (19.0% below peak).
2019 marks the peak diluted EPS at $6.72, with the historical low of $-28.05 recorded in 2022.
Within Healthcare, Illumina (ILMN) ranks 8th among 8 peers we track. The peer median for diluted EPS is $13.16.
Illumina EPS (Diluted) by Year
Illumina EPS (Diluted) 2025: $5.44
Illumina diluted EPS in 2025 was $5.44, plunged 170.7% below 2024.
Illumina EPS (Diluted) 2024: $-7.69
Illumina diluted EPS in 2024 was $-7.69, edged up 4.6% from 2023.
Illumina EPS (Diluted) 2023: $-7.35
Illumina diluted EPS in 2023 was $-7.35, plunged 73.8% below 2022.
Illumina EPS (Diluted) 2022: $-28.05
Illumina diluted EPS in 2022 was $-28.05, plunged 655.4% below 2021. This figure represents the lowest annual value in the available history.
Illumina EPS (Diluted) 2021: $5.05
Illumina diluted EPS in 2021 was $5.05.
See more financial history for Illumina (ILMN).
Sector peers — EPS (Diluted)
Companies in the same sector as Illumina, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Illumina's diluted EPS?
- Latest reported diluted EPS for Illumina (ILMN) is $5.44 (period ending December 28, 2025).
How has Illumina diluted EPS changed year-over-year?
- Illumina (ILMN) diluted EPS changed -170.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Illumina diluted EPS?
- Illumina (ILMN) diluted EPS compound annual growth rate is +4.2% over the most recent 5 years available.
When did Illumina diluted EPS hit its highest annual value?
- Illumina diluted EPS reached its highest annual value of $6.72 in 2019.
What was Illumina diluted EPS in 2024?
- Illumina (ILMN) diluted EPS in 2024 was $-7.69.
What was Illumina diluted EPS in 2025?
- Illumina (ILMN) diluted EPS in 2025 was $5.44.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ILMN Overview
Company profile, financial tools, and key metrics
ILMN Revenue Counter
Earns $137.68 every second. See per minute, hour, and day.
ILMN Earnings Counter
Earns $26.95 per second net profit. See per minute, hour, and day.
ILMN Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
ILMN What If Invested
What if you had invested $1,000? See historical returns from any date.
ILMN How It Makes Money
Discover visual breakdown of $4.34B in revenue — where it comes from and where it goes.
ILMN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ILMN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ILMN Daily Price Character
Explosive · 50.0% historical win rate (green days). Streaks & record days.
ILMN Buybacks
3.61% TTM buyback yield. Shareholder yield & SBC comparison.
ILMN Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.